Gut–lung axis: The microbial contributions and clinical implications

Critical Reviews in Microbiology

Volumn 43, Issue 1, 2017, Pages 81-95

  He, Yang ^a   Wen, Qu ^a   Yao, Fangfang ^a   Xu, Dong ^a   Huang, Yuancheng ^a   Wang, Junshuai ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Common mucosal immune; gut lung axis; microbiota

Indexed keywords

ACUTE LUNG INJURY; ASTHMA; BLOOD FLOW; CHRONIC DISEASE; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; DISEASE COURSE; DISEASE EXACERBATION; ENTEROPATHY; GASTROINTESTINAL MUCOSA; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; IMMUNE SYSTEM; INTESTINE FLORA; INTESTINE INNERVATION; LUNG; MICROFLORA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; REVIEW; ANIMAL; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; IMMUNOLOGY; LUNG DISEASE; MICROBIOLOGY;

ANIMALS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; LUNG; LUNG DISEASES; MICROBIOTA;

EID: 85008467240     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.1080/1040841X.2016.1176988     Document Type: Review

References (180)

1. Abt MC, Artis D. (2009). The intestinal microbiota in health and disease:the influence of microbial products on immune cell homeostasis. Curr Opin Gastroenterol 25:496–502.
2. Actis GC. (2014). The gut microbiome. Inflamm Allergy Drug Targets 13:217–23.
3. Adams CA, Jr., Hauser CJ, Adams JM, et al. (2002). Trauma-hemorrhage-induced neutrophil priming is prevented by mesenteric lymph duct ligation. Shock 18:513–7.
4. Albert RK, Connett J, Bailey WC, et al. (2011). Azithromycin for prevention of exacerbations of COPD. N Engl J Med 365:689–98.
5. AlFaleh K, Anabrees J. (2014). Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evid Based Child Health 9:584–671.
6. Alkhawaja S, Martin C, Butler RJ, et al. (2015). Post-pyloric versus gastric tube feeding for preventing pneumonia and improving nutritional outcomes in critically ill adults. Cochrane Database Syst Rev 8:CD008875.
7. Andoh A, Benno Y, Kanauchi O, et al. (2009). Recent advances in molecular approaches to gut microbiota in inflammatory bowel disease. Curr Pharm Des 15:2066–73.
8. Annane D, Clair B, Mathieu B, et al. (1996). Immunoglobulin A levels in bronchial samples during mechanical ventilation and onset of nosocomial pneumonia in critically ill patients. Am J Respir Crit Care Med 153:1585–90.
9. Atarashi K, Tanoue T, Oshima K, et al. (2013). Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500:232–6.
10. Atarashi K, Umesaki Y, Honda K. (2011). Microbiotal influence on T cell subset development. Semin Immunol 23:146–53.
11. Barfod KK, Roggenbuck M, Hansen LH, et al. (2013). The murine lung microbiome in relation to the intestinal and vaginal bacterial communities. BMC Microbiol 13:303.
12. Beck JM, Young VB, Huffnagle GB. (2012). The microbiome of the lung. Transl Res 160:258–66.
13. Ben-Horin S, Chowers Y. (2008). Neuroimmunology of the gut:physiology, pathology, and pharmacology. Curr Opin Pharmacol 8:490–5.
14. Ben DF, Yu XY, Ji GY, et al. (2012). TLR4 mediates lung injury and inflammation in intestinal ischemia-reperfusion. J Surg Res 174:326–33.
15. Bergqvist P, Stensson A, Lycke NY, et al. (2010). T cell-independent IgA class switch recombination is restricted to the GALT and occurs prior to manifest germinal center formation. J Immunol 184:3545–53.
16. Bibiloni R, Mangold M, Madsen KL, et al. (2006). The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol 55:1141–9.
17. Borovikova LV, Ivanova S, Zhang M, et al. (2000). Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458–62.
18. Brandtzaeg P. (2003). Mucosal immunity:integration between mother and the breast-fed infant. Vaccine 21:3382–8.
19. Brandtzaeg P. (2009). Mucosal immunity:induction, dissemination, and effector functions. Scand J Immunol 70:505–15.
20. Brandtzaeg P. (2010a). Function of mucosa-associated lymphoid tissue in antibody formation. Immunol Invest 39:303–55.
21. Brandtzaeg P. (2010b). The mucosal immune system and its integration with the mammary glands. J Pediatr 156:S8–S15.
22. Brandtzaeg P. (2011a). Immune functions of nasopharyngeal lymphoid tissue. Adv Otorhinolaryngol 72:20–4.
23. Brandtzaeg P. (2011b). Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways. Am J Respir Crit Care Med 183:1595–604.
24. Brandtzaeg P. (2013). Secretory IgA:designed for anti-microbial defense. Front Immunol 4:222.
25. Brandtzaeg P, Johansen FE. (2005). Mucosal B cells:phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev 206:32–63.
26. Brusselle GG, Joos GF, Bracke KR. (2011). New insights into the immunology of chronic obstructive pulmonary disease. Lancet 378:1015–26.
27. Buffie CG, Pamer EG. (2013). Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 13:790–801.
28. Burcelin R, Garidou L, Pomie C. (2012). Immuno-microbiota cross and talk:the new paradigm of metabolic diseases. Semin Immunol 24:67–74.
29. Caesar R, Tremaroli V, Kovatcheva-Datchary P, et al. (2015). Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab 22:658–68.
30. Chen LW, Chen PH, Hsu CM. (2011). Commensal microflora contribute to host defense against Escherichia coli pneumonia through Toll-like receptors. Shock 36:67–75.
31. Chen MM, Zahs A, Brown MM, et al. (2014). An alteration of the gut-liver axis drives pulmonary inflammation after intoxication and burn injury in mice. Am J Physiol Gastrointest Liver Physiol 307:G711–8.
32. Chen SJ, Liu XW, Liu JP, et al. (2014). Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier. World J Gastroenterol 20:9468–75.
33. Clancy RL, Dunkley M. (2011). Acute exacerbations in COPD and their control with oral immunization with non-typeable haemophilus influenzae. Front Immunol 2:7.
34. Clemente JC, Ursell LK, Parfrey LW, et al. (2012). The impact of the gut microbiota on human health:an integrative view. Cell 148:1258–70.
35. Cooke KR, Hill GR, Gerbitz A, et al. (2000). Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome:potential role for a gut–lung axis of inflammation. J Immunol 165:6612–9.
36. Coopersmith CM, Stromberg PE, Davis CG, et al. (2003). Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest. Crit Care Med 31:1630–7.
37. Costantini TW, Krzyzaniak M, Cheadle GA, et al. (2012). Targeting alpha-7 nicotinic acetylcholine receptor in the enteric nervous system:a cholinergic agonist prevents gut barrier failure after severe burn injury. Am J Pathol 181:478–86.
38. D'Alessandro A, Dzieciatkowska M, Peltz ED, et al. (2014). Dynamic changes in rat mesenteric lymph proteins following trauma using label-free mass spectrometry. Shock 42:509–17.
39. de Steenhuijsen Piters WA, Sanders EA, Bogaert D. (2015). The role of the local microbial ecosystem in respiratory health and disease. Philos Trans R Soc Lond B Biol Sci 370. DOI:10.1098/rstb.2014.0294.
40. Deitch EA. (2001). Role of the gut lymphatic system in multiple organ failure. Curr Opin Crit Care 7:92–8.
41. Deitch EA, Adams CA, Lu Q, et al. (2001). Mesenteric lymph from rats subjected to trauma-hemorrhagic shock are injurious to rat pulmonary microvascular endothelial cells as well as human umbilical vein endothelial cells. Shock 16:290–3.
42. Deitch EA, Xu D, Kaise VL. (2006). Role of the gut in the development of injury- and shock induced SIRS and MODS:the gut-lymph hypothesis, a review. Front Biosci 11:520–8.
43. Desai SV, McClave SA, Rice TW. (2014). Nutrition in the ICU:an evidence-based approach. Chest 145:1148–57.
44. Deshmukh HS, Liu Y, Menkiti OR, et al. (2014). The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med 20:524–30.
45. Dickson RP, Erb-Downward JR, Huffnagle GB. (2013). The role of the bacterial microbiome in lung disease. Expert Rev Respir Med 7:245–57.
46. Dickson RP, Martinez FJ, Huffnagle GB. (2014). The role of the microbiome in exacerbations of chronic lung diseases. Lancet 384:691–702.
47. Duchmann R. (2006). The role of probiotics and antibiotics in regulating mucosal inflammation. Adv Exp Med Biol 579:219–26.
48. Dzieciatkowska M, D'Alessandro A, Moore EE, et al. (2014). Lymph is not a plasma ultrafiltrate:a proteomic analysis of injured patients. Shock 42:485–98.
49. Dzieciatkowska M, Wohlauer MV, Moore EE, et al. (2011). Proteomic analysis of human mesenteric lymph. Shock 35:331–8.
50. Ekbom A, Brandt L, Granath F, et al. (2008). Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD. Lung 186:167–72.
51. Erb-Downward JR, Huffnagle GB, Martinez FJ. (2012). The microbiota in respiratory disease. Am J Respir Crit Care Med 185:1037–8.
52. Fagarasan S. (2006). Intestinal IgA synthesis:a primitive form of adaptive immunity that regulates microbial communities in the gut. Curr Top Microbiol Immunol 308:137–53.
53. Fagarasan S, Honjo T. (2003). Intestinal IgA synthesis:regulation of front-line body defences. Nat Rev Immunol 3:63–72.
54. Fahy JV. (2013). Chair's summary:mechanisms of relevance to clinical heterogeneity of asthma and chronic obstructive pulmonary disease. Ann Am Thorac Soc 10:S108.
55. Farkas AM, Panea C, Goto Y, et al. (2015). Induction of Th17 cells by segmented filamentous bacteria in the murine intestine. J Immunol Methods 421:104–11.
56. Feng T, Elson CO. (2011). Adaptive immunity in the host-microbiota dialog. Mucosal Immunol 4:15–21.
57. Fox AC, McConnell KW, Yoseph BP, et al. (2012). The endogenous bacteria alter gut epithelial apoptosis and decrease mortality following Pseudomonas aeruginosa pneumonia. Shock 38:508–14.
58. Garcia-Nunez M, Millares L, Pomares X, et al. (2014). Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease. J Clin Microbiol 52:4217–23.
59. Garzoni C, Brugger SD, Qi W, et al. (2013). Microbial communities in the respiratory tract of patients with interstitial lung disease. Thorax 68:1150–6.
60. Gommerman JL, Rojas OL, Fritz JH. (2014). Re-thinking the functions of IgA(+) plasma cells. Gut Microbes 5:652–62.
61. Gorman S, Weeden CE, Tan DH, et al. (2013). Reversible control by vitamin D of granulocytes and bacteria in the lungs of mice:an ovalbumin-induced model of allergic airway disease. PLoS One 8:e67823.
62. Gullberg E, Soderholm JD. (2006). Peyer's patches and M cells as potential sites of the inflammatory onset in Crohn's disease. Ann N Y Acad Sci 1072:218–32.
63. Hamelmann E, Herz U, Holt P, et al. (2008). New visions for basic research and primary prevention of pediatric allergy:an iPAC summary and future trends. Pediatr Allergy Immunol 19:4–16.
64. Han MK, Huang YJ, Lipuma JJ, et al. (2012). Significance of the microbiome in obstructive lung disease. Thorax 67:456–63.
65. Hildebrandt GC, Olkiewicz KM, Corrion LA, et al. (2004). Donor-derived TNF-alpha regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation. Blood 104:586–93.
66. Hill DA, Artis D. (2010). Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol 28:623–67.
67. Hill DA, Hoffmann C, Abt MC, et al. (2010). Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 3:148–58.
68. Hilty M, Burke C, Pedro H, et al. (2010). Disordered microbial communities in asthmatic airways. PLoS One 5:e8578.
69. Hoen AG, Li J, Moulton LA, et al. (2015). Associations between gut microbial colonization in early life and respiratory outcomes in cystic fibrosis. J Pediatr 167:138–47. e131–133.
70. Hooper LV, Littman DR, Macpherson AJ. (2012). Interactions between the microbiota and the immune system. Science 336:1268–73.
71. Huang YJ, Boushey HA. (2015). The microbiome in asthma. J Allergy Clin Immunol 135:25–30.
72. Huang YJ, Nelson CE, Brodie EL, et al. (2011). Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 127:372–81. e371–373.
73. Huffnagle GB, Dickson RP. (2015). The bacterial microbiota in inflammatory lung diseases. Clin Immunol. 159:177–82.
74. Jennings S, Prescott SL. (2010). Early dietary exposures and feeding practices:role in pathogenesis and prevention of allergic disease? Postgrad Med J 86:94–9.
75. Johansson ME, Gustafsson JK, Holmen-Larsson J, et al. (2014). Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 63:281–91.
76. Kalogeris T, Baines CP, Krenz M, et al. (2012). Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol 298:229–317.
77. Kanangat S, Meduri GU, Tolley EA, et al. (1999). Effects of cytokines and endotoxin on the intracellular growth of bacteria. Infect Immun 67:2834–40.
78. Kang W, Kudsk KA. (2007). Is there evidence that the gut contributes to mucosal immunity in humans? JPEN J Parenter Enteral Nutr 31:246–58.
79. Keely S, Hansbro PM. (2014). Lung-gut cross talk:a potential mechanism for intestinal dysfunction in patients with COPD. Chest 145:199–200.
80. Khader SA, Gaffen SL, Kolls JK. (2009). Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol 2:403–11.
81. Khoruts A, Sadowsky MJ. (2011). Therapeutic transplantation of the distal gut microbiota. Mucosal Immunol 4:4–7.
82. Kiyono H, Fukuyama S. (2004). NALT-versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol 4:699–710.
83. Krzyzaniak MJ, Peterson CY, Cheadle G, et al. (2011). Efferent vagal nerve stimulation attenuates acute lung injury following burn:the importance of the gut–lung axis. Surgery 150:379–89.
84. Kudsk KA. (2002). Current aspects of mucosal immunology and its influence by nutrition. Am J Surg 183:390–8.
85. Kudsk KA, Gomez FE, Kang W, et al. (2007). Enteral feeding of a chemically defined diet preserves pulmonary immunity but not intestinal immunity:the role of lymphotoxin beta receptor. JPEN J Parenter Enteral Nutr 31:477–81.
86. Lee YK, Mazmanian SK. (2010). Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 330:1768–73.
87. Lee YT, Kim KH, Hwang HS, et al. (2015). Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection. Virology 485:36–46.
88. Lennon G, Balfe A, Earley H, et al. (2014). Influences of the colonic microbiome on the mucous gel layer in ulcerative colitis. Gut Microb 5:277–85.
89. Levy G, Fishman JE, Xu D, et al. (2013). Parasympathetic stimulation via the vagus nerve prevents systemic organ dysfunction by abrogating gut injury and lymph toxicity in trauma and hemorrhagic shock. Shock 39:39–44.
90. Linskens RK, Huijsdens XW, Savelkoul PH, et al. (2001). The bacterial flora in inflammatory bowel disease:current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol (Suppl):29–40.
91. Liu L, Gao Z, Xia C, et al. (2012). Comparative study of trans-oral and trans-tracheal intratracheal instillations in a murine model of acute lung injury. Anat Rec (Hoboken) 295:1513–9.
92. Looft T, Allen HK. (2012). Collateral effects of antibiotics on mammalian gut microbiomes. Gut Microbes 3:463–7.
93. Luyer MD, de Haan, JJ, Lubbers T, et al. (2013). Parasympathetic stimulation via the vagus nerve prevents systemic organ dysfunction by abrogating gut injury and lymph toxicity in trauma and hemorrhagic shock. Shock 39:460–1.
94. Ly NP, Litonjua A, Gold DR, et al. (2011). Gut microbiota, probiotics, and vitamin D:interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol 127:1087–94. quiz 1095–86.
95. Magnotti LJ, Upperman JS, Xu DZ, et al. (1998). Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock. Ann Surg 228:518–27.
96. Man AL, Prieto-Garcia ME, Nicoletti C. (2004). Improving M cell mediated transport across mucosal barriers:do certain bacteria hold the keys? Immunology 113:15–22.
97. Marks LR, Davidson BA, Knight PR, et al. (2013). Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease. MBio 4:e00438–13.
98. Marri PR, Stern DA, Wright AL, et al. (2013). Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol 131:346–52. e341–343.
99. Martin C, Burgel PR, Lepage P, et al. (2015). Host–microbe interactions in distal airways:relevance to chronic airway diseases. Eur Respir Rev 24:78–91.
100. Matsuno K, Ueta H, Shu Z, et al. (2010). The microstructure of secondary lymphoid organs that support immune cell trafficking. Arch Histol Cytol 73:1–21.
101. McAleer JP, Kolls JK. (2014). Directing traffic:IL-17 and IL-22 coordinate pulmonary immune defense. Immunol Rev 260:129–44.
102. McGhan LJ, Jaroszewski DE. (2012). The role of toll-like receptor-4 in the development of multi-organ failure following traumatic haemorrhagic shock and resuscitation. Injury 43:129–36.
103. McLean MH, Dieguez D, Jr., Miller LM, et al. (2015). Does the microbiota play a role in the pathogenesis of autoimmune diseases? Gut 64:332–41.
104. McLoughlin RM, Mills KH. (2011). Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. J Allergy Clin Immunol 127:1097–107. quiz 1108–99.
105. Merga Y, Campbell BJ, Rhodes JM. (2014). Mucosal barrier, bacteria and inflammatory bowel disease:possibilities for therapy. Dig Dis 32:475–83.
106. Miravitlles M, Anzueto A. (2015). Role of infection in exacerbations of chronic obstructive pulmonary disease. Curr Opin Pulm Med 21:278–83.
107. Mittal R, Coopersmith CM. (2014). Redefining the gut as the motor of critical illness. Trends Mol Med 20:214–23.
108. Modi SR JJ., Collins DA, Relman (2014). Antibiotics and the gut microbiota. J Clin Invest 124:4212–8.
109. Mollen KP, Anand RJ, Tsung A, et al. (2006). Emerging paradigm:toll-like receptor 4-sentinel for the detection of tissue damage. Shock 26:430–7.
110. Molloy MJ, Bouladoux N, Belkaid Y. (2012). Intestinal microbiota:shaping local and systemic immune responses. Semin Immunol 24:58–66.
111. Molyneaux PL, Mallia P, Cox MJ, et al. (2013). Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 188:1224–31.
112. Morishita K, Costantini TW, Ueno A, et al. (2015). A pharmacologic approach to vagal nerve stimulation prevents mesenteric lymph toxicity after hemorrhagic shock. J Trauma Acute Care Surg 78:52–8. discussion 58–9.
113. Nagano Y, Itoh K, Honda K. (2012). The induction of Treg cells by gut-indigenous Clostridium. Curr Opin Immunol 24:392–7.
114. Nicod LP, Kolls JK. (2015). Chair's summary:mechanisms of exacerbation of lung diseases. Ann Am Thorac Soc 12:S112–S4.
115. Nishio J, Honda K. (2012). Immunoregulation by the gut microbiota. Cell Mol Life Sci 69:3635–50.
116. Olszak T, An D, Zeissig S, et al. (2012). Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336:489–93.
117. Orivuori L, Mustonen K, de Goffau MC, et al. (2015). High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6. Clin Exp Allergy 45:928–39.
118. Osband AJ, Deitch EA, Hauser CJ, et al. (2004). Albumin protects against gut-induced lung injury in vitro and in vivo. Ann Surg 240:331–9.
119. Ouwehand AC, Nermes M, Collado MC, et al. (2009). Specific probiotics alleviate allergic rhinitis during the birch pollen season. World J Gastroenterol 15:3261–8.
120. Pammi M, Abrams SA. (2015). Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2:CD007137.
121. Panoskaltsis-Mortari A, Griese M, Madtes DK, et al. (2011). An official American Thoracic Society research statement:noninfectious lung injury after hematopoietic stem cell transplantation:idiopathic pneumonia syndrome. Am J Respir Crit Care Med 183:1262–79.
122. Perrone EE, Jung E, Breed E, et al. (2012). Mechanisms of methicillin-resistant Staphylococcus aureus pneumonia-induced intestinal epithelial apoptosis. Shock 38:68–75.
123. Poroyko V, Meng F, Meliton A, et al. (2015). Alterations of lung microbiota in a mouse model of LPS-induced lung injury. Am J Physiol Lung Cell Mol Physiol 309:L76–83.
124. Pragman AA, Kim HB, Reilly CS, et al. (2012). The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One 7:e47305.
125. Prakash A, Mesa KR, Wilhelmsen K, et al. (2012). Alveolar macrophages and Toll-like receptor 4 mediate ventilated lung ischemia reperfusion injury in mice. Anesthesiology 117:822–35.
126. Prakash A, Sundar SV, Zhu YG, et al. (2015). Lung ischemia-reperfusion is a sterile inflammatory process influenced by commensal microbiota in mice. Shock 44:272–9.
127. Prescott S, Nowak-Wegrzyn A. (2011). Strategies to prevent or reduce allergic disease. Ann Nutr Metab 59:28–42.
128. Prescott SL. (2003). Early origins of allergic disease:a review of processes and influences during early immune development. Curr Opin Allergy Clin Immunol 3:125–32.
129. Price KE, Hampton TH, Gifford AH, et al. (2013). Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation. Microbiome 1:27.
130. Prince JM, Levy RM, Yang R, et al. (2006). Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock. J Am Coll Surg 202:407–17.
131. Qin J, Li R, Raes J, et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59–65.
132. Rehman A, Lepage P, Nolte A, et al. (2010). Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients. J Med Microbiol 59:1114–22.
133. Risnes KR, Belanger K, Murk W, et al. (2011). Antibiotic exposure by 6 months and asthma and allergy at 6 years:findings in a cohort of 1,401 US children. Am J Epidemiol 173:310–8.
134. Rupani B, Caputo FJ, Watkins AC, et al. (2007). Relationship between disruption of the unstirred mucus layer and intestinal restitution in loss of gut barrier function after trauma hemorrhagic shock. Surgery 141:481–9.
135. Russell SL, Gold MJ, Hartmann M, et al. (2012). Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep 13:440–7.
136. Russell SL, Gold MJ, Willing BP, et al. (2013). Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes 4:158–64.
137. Rutten EP, Lenaerts K, Buurman WA, et al. (2014). Disturbed intestinal integrity in patients with COPD:effects of activities of daily living. Chest 145:245–52.
138. Samuelson DR, Welsh DA, Shellito JE. (2015). Regulation of lung immunity and host defense by the intestinal microbiota. Front Microbiol 6:1085.
139. Schmidt A, Belaaouaj A, Bissinger R, et al. (2014). Neutrophil elastase-mediated increase in airway temperature during inflammation. J Cyst Fibros 13:623–31.
140. Sefik E, Geva-Zatorsky N, Oh S, et al. (2015). Mucosal immunology. Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells. Science 349:993–7.
141. Segal LN, Blaser MJ. (2014). A brave new world:the lung microbiota in an era of change. Ann Am Thorac Soc 11:S21–S7.
142. Segal LN, Rom WN, Weiden MD. (2014). Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs. Ann Am Thorac Soc 11:108–16.
143. Shan M, Cheng HF, Song LZ, et al. (2009). Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema. Sci Transl Med 1:4ra10.
144. Sheil B, Shanahan F, O'Mahony L. (2007). Probiotic effects on inflammatory bowel disease. J Nutr 137:819S–24S.
145. Sheth SU, Palange D, Xu DZ, et al. (2011). Testosterone depletion or blockade in male rats protects against trauma hemorrhagic shock-induced distant organ injury by limiting gut injury and subsequent production of biologically active mesenteric lymph. J Trauma 71:1652–8.
146. Shimizu K, Ogura H, Asahara T, et al. (2013). Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective. Dig Dis Sci 58:23–32.
147. Son JY, Chandler B, Feketova E, et al. (2014). Oral pretreatment with recombinant human lactoferrin limits trauma-hemorrhagic shock-induced gut injury and the biological activity of mesenteric lymph. J Surg Res 187:270–7.
148. Souza DG, Vieira AT, Soares AC, et al. (2004). The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J Immunol 173:4137–46.
149. Swidsinski A, Loening-Baucke V, Theissig F, et al. (2007). Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut 56:343–50.
150. Sze MA, Dimitriu PA, Hayashi S, et al. (2012). The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 185:1073–80.
151. Sze MA, Tsuruta M, Yang SW, et al. (2014). Changes in the bacterial microbiota in gut, blood, and lungs following acute LPS instillation into mice lungs. PLoS One 9:e111228.
152. Tanabe S. (2013). The effect of probiotics and gut microbiota on Th17 cells. Int Rev Immunol 32:511–25.
153. Tandon MK, Phillips M, Waterer G, et al. (2010). Oral immunotherapy with inactivated nontypeable Haemophilus influenzae reduces severity of acute exacerbations in severe COPD. Chest 137:805–11.
154. Teo E, House H, Lockhart K, et al. (2014). Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Cochrane Database Syst Rev 9:CD010010.
155. Tracy M, Cogen J, Hoffman LR. (2015). The pediatric microbiome and the lung. Curr Opin Pediatr 27:348–55.
156. Traves SL, Donnelly LE. (2008). Th17 cells in airway diseases. Curr Mol Med 8:416–26.
157. Tsay TB, Yang MC, Chen PH, et al. (2011). Gut flora enhance bacterial clearance in lung through toll-like receptors 4. J Biomed Sci 18:68.
158. Ubeda C, Pamer EG. (2012). Antibiotics, microbiota, and immune defense. Trends Immunol 33:459–66.
159. Ueta H, Shi C, Miyanari N, et al. (2008). Systemic transmigration of allosensitizing donor dendritic cells to host secondary lymphoid organs after rat liver transplantation. Hepatology 47:1352–62.
160. van Nood E, Vrieze A, Nieuwdorp M, et al. (2013). Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368:407–15.
161. Vanaudenaerde BM, Verleden SE, Vos R, et al. (2011). Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders. Am J Respir Crit Care Med 183:977–86.
162. Vanderpool C, Yan F, Polk DB. (2008). Mechanisms of probiotic action:implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 14:1585–96.
163. Vargas-Rojas MI, Ramirez-Venegas A, Limon-Camacho L, et al. (2011). Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Med 105:1648–54.
164. Viaud S, Saccheri F, Mignot G, et al. (2013). The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342:971–6.
165. Vital M, Harkema JR, Rizzo M, et al. (2015). Alterations of the murine gut microbiome with age and allergic airway disease. J Immunol Res 2015:892568.
166. Vongbhavit K, Underwood MA. (2016). Prevention of necrotizing enterocolitis through manipulation of the intestinal microbiota of the premature infant. Clin Ther 38:716–32.
167. Walker AW, Sanderson JD, Churcher C, et al. (2011). High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 11:7.
168. Wang H, Peng W, Weng Y, et al. (2012). Imbalance of Th17/Treg cells in mice with chronic cigarette smoke exposure. Int Immunopharmacol 14:504–12.
169. Wang H, Ying H, Wang S, et al. (2015). Imbalance of peripheral blood Th17 and Treg responses in patients with chronic obstructive pulmonary disease. Clin Respir J 9:330–41.
170. Wang J, Li F, Sun R, et al. (2013). Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages. Nat Commun 4:2106.
171. West CE, D'Vaz N, Prescott SL. (2011). Dietary immunomodulatory factors in the development of immune tolerance. Curr Allergy Asthma Rep 11:325–33.
172. Wohlauer MV, Moore EE, Harr J, et al. (2011). Cross-transfusion of postshock mesenteric lymph provokes acute lung injury. J Surg Res 170:314–8.
173. Wong C, Jayaram L, Karalus N, et al. (2012). Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE):a randomised, double-blind, placebo-controlled trial. Lancet 380:660–7.
174. Xu D, Huang Y, Wang J. (2015). Gut microbiota modulate the immune effect against hepatitis B virus infection. Eur J Clin Microbiol Infect Dis 34:2139–47.
175. Xu D, Zhao M, Song Y, et al. (2015). Novel insights in preventing Gram-negative bacterial infection in cirrhotic patients:review on the effects of GM-CSF in maintaining homeostasis of the immune system. Hepatol Int 9:28–34.
176. Yan F, Polk DB. (2010). Probiotics:progress toward novel therapies for intestinal diseases. Curr Opin Gastroenterol 26:95–101.
177. Yan F, Polk DB. (2011). Probiotics and immune health. Curr Opin Gastroenterol 27:496–501.
178. Zhang MQ, Wan Y, Jin Y, et al. (2014). Cigarette smoking promotes inflammation in patients with COPD by affecting the polarization and survival of Th/Tregs through up-regulation of muscarinic receptor 3 and 5 expression. PLoS One 9:e112350.
179. Zhou L, Lopes JE, Chong MM, et al. (2008). TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453:236–40.
180. Zou Y, Dong C, Yuan M, et al. (2014). Instilled air promotes lipopolysaccharide-induced acute lung injury. Exp Ther Med 7:816–20.